Literature DB >> 24984975

Awash in a sea of 'bath salts': implications for biomedical research and public health.

Michael H Baumann1.   

Abstract

Entities:  

Keywords:  Bath salts; MDPV; cathinone; dopamine; mephedrone; methylone; transporter

Mesh：

Substances：

Year:  2014        PMID： 24984975      PMCID： PMC4896154          DOI： 10.1111/add.12601

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  17 in total

Review 1.  The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).

Authors:  Paul I Dargan; Roumen Sedefov; Ana Gallegos; David M Wood
Journal:  Drug Test Anal       Date:  2011-07-13       Impact factor: 3.345

2.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

3.  Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.

Authors:  Henry A Spiller; Mark L Ryan; Robert G Weston; Joanne Jansen
Journal:  Clin Toxicol (Phila)       Date:  2011-07       Impact factor: 4.467

4.  Establishment of drug codes for 26 substances. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2013-01-04

Review 5.  Abuse liability of novel 'legal high' designer stimulants: evidence from animal models.

Authors:  Lucas R Watterson; Elizabeth Watterson; Michael Foster Olive
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

Review 6.  Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.

Authors:  Edward A Ross; Gary M Reisfield; Mary C Watson; Chris W Chronister; Bruce A Goldberger
Journal:  Am J Med       Date:  2012-06-09       Impact factor: 4.965

7.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 8.  Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

Authors:  Richard A Glennon
Journal:  Adv Pharmacol       Date:  2014

9.  Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry.

Authors:  Marta Concheiro; Sebastien Anizan; Kayla Ellefsen; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-10-03       Impact factor: 4.142

10.  Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.

Authors:  Kevin G Shanks; Tim Dahn; George Behonick; Andrea Terrell
Journal:  J Anal Toxicol       Date:  2012-05-14       Impact factor: 3.367
View more
  20 in total

1.  Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.

Authors:  Megan E Patrick; Patrick M O'Malley; Deborah D Kloska; John E Schulenberg; Lloyd D Johnston; Richard A Miech; Jerald G Bachman
Journal:  Drug Alcohol Rev       Date:  2015-12-29

2.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

3.  Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study.

Authors:  Susan M Lantz; Hector Rosas-Hernandez; Elvis Cuevas; Bonnie Robinson; Kenner C Rice; William E Fantegrossi; Syed Z Imam; Merle G Paule; Syed F Ali
Journal:  Neurosci Lett       Date:  2017-07-03       Impact factor: 3.046

Review 4.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

5.  Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats.

Authors:  Julie A Marusich; Elaine A Gay; Bruce E Blough
Journal:  Psychopharmacology (Berl)       Date:  2018-09-06       Impact factor: 4.530

6.  Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.

Authors:  S L Huskinson; J E Naylor; E A Townsend; J K Rowlett; B E Blough; K B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2016-11-28       Impact factor: 4.530

7.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

Review 8.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

9.  Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences.

Authors:  Heather E King; Alison Wakeford; William Taylor; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2015-07-26       Impact factor: 3.533

10.  Synthetic cathinone self-administration in female rats modulates neurotransmitter levels in addiction-related brain regions.

Authors:  Julie A Marusich; Elaine A Gay; Scott L Watson; Bruce E Blough
Journal:  Behav Brain Res       Date:  2019-09-04       Impact factor: 3.332
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.